Andrea D. Olmstead

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion et al. · Nature · 2022 · 232 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +15

Human Subtilase SKI-1/S1P Is a Master Regulator of the HCV Lifecycle and a Potential Host Cell Target for Developing Indirect-Acting Antiviral Agents

Andrea D. Olmstead, Wolfgang Knecht, Ina Lazarov et al. · PLoS Pathogens · 2012 · 78 citations · Full text

Life Sciences, Biochemistry, Infectious Diseases +17

Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada

Brendan Jacka, Tanya Applegate, Mel Krajden et al. · Hepatology · 2014 · 72 citations · Full text

Life Sciences, Infectious Diseases, Molecular Virology +16

The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study

Jeffrey B. Joy, Rosemary M. McCloskey, Thuy Nguyen et al. · The Lancet Infectious Diseases · 2016 · 48 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9

Anastasia Hyrina, Andrea D. Olmstead, Paul Steven et al. · EBioMedicine · 2017 · 36 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17